“We rely every bit on our indigenous technology”- Mr CL Rathi’s Coverage in Biospectrum

In a market dominated by multinational companies, homegrown company, Advanced Enzymes Technologies Limited has performed commendably, clocking revenues of Rs 175 Crore (As of December 2011) and chalked out an ambitious plan for the year on year growth of 30-35 percent to reach the Rs 100 crore mark in the next five to eight years, This apart, The company is also looking at a massive expansion of its production capacity and penetration to different geographies of the world in a conversation with BioSpectrum, Mr CL Rathi, CEO, Advanced Enzymes Technologies, gives an insight in to company’s game plan for the future.

Click to view PDF

Request a call back